These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6697330)

  • 1. Phase II chemotherapy trials of 5-FU, cyclophosphamide, ifosfamide, and vincristine in carcinoma of the bilharzial bladder.
    Gad-el-Mawla N; Ziegler JL; Hamza R; Elserafi M; Khaled H
    Cancer Treat Rep; 1984 Feb; 68(2):419-21. PubMed ID: 6697330
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapeutic management of carcinoma of the bilharzial bladder: a phase II trial with hexamethylmelamine and VM-26.
    Gad-el-Mawla NM; Muggia FM; Hamza MR; El-Morsi B; Sherif M; Mansour MA; Khafagy M; El-Sebai IT
    Cancer Treat Rep; 1978 Jul; 62(7):993-6. PubMed ID: 99234
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II trial of methotrexate in carcinoma of the bilharzial bladder.
    Gad-el-Mawla N; Hamsa R; Cairns J; Anderson T; Ziegler JL
    Cancer Treat Rep; 1978 Jul; 62(7):1075-6. PubMed ID: 356969
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized phase II trial of hexamethylmelamine versus pentamethylmelamine in carcinoma of the bilharzial bladder.
    Gad-el-Mawla N; Ziegler JL; Hamza R; Elserafi M; Khaled H
    Cancer Treat Rep; 1984 May; 68(5):793-4. PubMed ID: 6426792
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II randomized study of doxorubicin, vincristine, and 5-FU versus cyclophosphamide in advanced squamous cell carcinoma of the cervix.
    Omura GA; Vélez-García E; Birch R
    Cancer Treat Rep; 1981; 65(9-10):901-3. PubMed ID: 7196801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma.
    Morgan LR; Posey LE; Rainey J; Bickers J; Ryan D; Vial R; Hull EW
    Cancer Treat Rep; 1981; 65(7-8):693-5. PubMed ID: 6265084
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study of intravenous ifosfamide plus oral acetylcysteine in the treatment of non-small cell lung cancer.
    Saiers JH; Slavik M
    Vet Hum Toxicol; 1981; 23(Suppl 1):12-4. PubMed ID: 6272470
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cytostatic treatment of hypernephroid renal carcinoma (author's transl)].
    König HJ; Hartwich G
    Dtsch Med Wochenschr; 1980 Dec; 105(52):1810-4. PubMed ID: 7449648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experiences with holoxan within the framework of sequential combination therapy (author's transl)].
    Hartwich G; Neidhardt B; Lutz H
    Med Klin; 1978 Sep; 73(36):1247-52. PubMed ID: 692477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vincristine in advanced bladder cancer: a European organization for research on treatment of cancer (EORTC) phase II study.
    Richards B; Newling D; Fossa S; Bastable JR; Denis L; Jones WB; de Pauw M
    Cancer Treat Rep; 1983 Jun; 67(6):575-7. PubMed ID: 6861163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy in multimodal management of rhabdomyosarcoma of bladder and prostate in children.
    Sutow WW; Johnson DE; Fernandez CH
    Urol Clin North Am; 1974 Oct; 1(3):607-15. PubMed ID: 4610953
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of secondary malignant lymphoma of the urinary bladder].
    Yokoyama M; Kobayashi T; Kubo Y; Kageyama Y; Kihara K
    Hinyokika Kiyo; 2006 Apr; 52(4):285-7. PubMed ID: 16686357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical studies of ifosfamide for gynecological malignancies].
    Kohno I; Kazuta M; Miyao J; Kunimi N; Kawamoto M; Tanimura T; Fujiwara K; Sekiba K
    Gan To Kagaku Ryoho; 1983 May; 10(5):1278-84. PubMed ID: 6870299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ifosfamide in the treatment of bronchogenic carcinoma. A preliminary trial.
    Gandola L; Pozzi E; Tansini G
    G Ital Chemioter; 1978; 25(1):41-4. PubMed ID: 376387
    [No Abstract]   [Full Text] [Related]  

  • 17. An analysis of a multiple-drug program in the treatment of patients with advanced breast cancer utilizing 5-fluorouracil, cyclophosphamide, and prednisone with or without vincristine.
    Ahmann DL; Bisel HF; Hahn RG; Eagan RT; Edmonson JH; Steinfeld JL; Tormey DC; Taylor WF
    Cancer; 1975 Dec; 36(6):1925-35. PubMed ID: 1203855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy of neuroblastomas].
    Fedi B; Di Silverio F; Coppola R
    Cancro; 1969; 22(5):483-502. PubMed ID: 5401720
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ifosfamide, methotrexate, and vincristine (IMV) combination chemotherapy as secondary treatment for patients with malignant lymphoma.
    Cabanillas F; Rodriguez V; Bodey GP
    Cancer Treat Rep; 1980; 64(8-9):933-7. PubMed ID: 7004634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.